Ben Atkins
Plus aucun poste en cours
Historique de carrière de Ben Atkins
Anciens postes connus de Ben Atkins
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Investor Relations Contact | - | 02/03/2023 |
| Public Communications Contact | - | 02/03/2023 |
Formation de Ben Atkins
| King's College London | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Bourse
- Insiders
- Ben Atkins
- Expérience
